OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Treatment with Tocilizumab in Adult Patients with Moderate to Critical COVID‐19 Pneumonia: A Single‐Center Retrospective Study
Amanda Rădulescu, Alexandru Istrate, Monica Muntean
International Journal of Infectious Diseases (2022) Vol. 117, pp. 1-7
Open Access | Times Cited: 13
Amanda Rădulescu, Alexandru Istrate, Monica Muntean
International Journal of Infectious Diseases (2022) Vol. 117, pp. 1-7
Open Access | Times Cited: 13
Showing 13 citing articles:
COVID-19 and Laboratory Markers from Romanian Patients—A Narrative Review
Ovidiu Mușat, Virgiliu Bogdan Sorop, Madalina Ioana Sorop, et al.
Life (2023) Vol. 13, Iss. 9, pp. 1837-1837
Open Access | Times Cited: 6
Ovidiu Mușat, Virgiliu Bogdan Sorop, Madalina Ioana Sorop, et al.
Life (2023) Vol. 13, Iss. 9, pp. 1837-1837
Open Access | Times Cited: 6
Effect of Tocilizumab on Mortality in Patients with SARS-CoV-2 Pneumonia Caused by Delta or Omicron Variants: A Propensity-Matched Analysis in Nimes University Hospital, France
Paul Laffont-Lozes, Didier Laureillard, Paul Loubet, et al.
Antibiotics (2023) Vol. 12, Iss. 1, pp. 88-88
Open Access | Times Cited: 4
Paul Laffont-Lozes, Didier Laureillard, Paul Loubet, et al.
Antibiotics (2023) Vol. 12, Iss. 1, pp. 88-88
Open Access | Times Cited: 4
Effectiveness of Tocilizumab in Patients with Severe or Critical Lung Involvement in COVID-19: A Retrospective Study
Daniel Chober, Bogusz Aksak‐Wąs, Katarzyna Bobrek‐Lesiakowska, et al.
Journal of Clinical Medicine (2022) Vol. 11, Iss. 9, pp. 2286-2286
Open Access | Times Cited: 7
Daniel Chober, Bogusz Aksak‐Wąs, Katarzyna Bobrek‐Lesiakowska, et al.
Journal of Clinical Medicine (2022) Vol. 11, Iss. 9, pp. 2286-2286
Open Access | Times Cited: 7
Effects of COVID-19 on the Liver and Mortality in Patients with SARS-CoV-2 Pneumonia Caused by Delta and Non-Delta Variants: An Analysis in a Single Centre
Monica Muntean, Violeta Briciu, Mihaela Lupșe, et al.
Pharmaceuticals (2023) Vol. 17, Iss. 1, pp. 3-3
Open Access | Times Cited: 3
Monica Muntean, Violeta Briciu, Mihaela Lupșe, et al.
Pharmaceuticals (2023) Vol. 17, Iss. 1, pp. 3-3
Open Access | Times Cited: 3
Prevalence of Hospital-Acquired Pneumonia Among Patients With Severe to Critical COVID-19 Pneumonia Given Tocilizumab
Lorenzo Abednego B. Adre, Josefino S Catangui, Marvin Keith V Bondoc, et al.
Cureus (2023)
Open Access | Times Cited: 2
Lorenzo Abednego B. Adre, Josefino S Catangui, Marvin Keith V Bondoc, et al.
Cureus (2023)
Open Access | Times Cited: 2
Evolving Clinical Manifestations and Outcomes in COVID-19 Patients: A Comparative Analysis of SARS-CoV-2 Variant Waves in a Romanian Hospital Setting
Violeta Briciu, Daniel-Corneliu Leucuța, Monica Muntean, et al.
Pathogens (2023) Vol. 12, Iss. 12, pp. 1453-1453
Open Access | Times Cited: 2
Violeta Briciu, Daniel-Corneliu Leucuța, Monica Muntean, et al.
Pathogens (2023) Vol. 12, Iss. 12, pp. 1453-1453
Open Access | Times Cited: 2
Efficacy of interleukin-6 inhibitors as a tool for preventive anti-inflammatory therapy for COVID-19
S. К. Zyryanov, О. И. Бутранова, A. A. Abramova
Kachestvennaya Klinicheskaya Praktika = Good Clinical Practice (2024), Iss. 1, pp. 4-16
Open Access
S. К. Zyryanov, О. И. Бутранова, A. A. Abramova
Kachestvennaya Klinicheskaya Praktika = Good Clinical Practice (2024), Iss. 1, pp. 4-16
Open Access
Pharmacotherapeutic Treatment Strategies COVID-19: Lessons Learned and Perspectives
Abdurashid Khamidovich Ashirmetov
Exploratory Research and Hypothesis in Medicine (2022) Vol. 000, Iss. 000, pp. 000-000
Open Access | Times Cited: 2
Abdurashid Khamidovich Ashirmetov
Exploratory Research and Hypothesis in Medicine (2022) Vol. 000, Iss. 000, pp. 000-000
Open Access | Times Cited: 2
Immunosuppressive drugs and their aerosol delivery for COVID-19 treatment
V. I. Kobylyansky
Fundamental and Clinical Medicine (2022) Vol. 7, Iss. 3, pp. 74-84
Open Access | Times Cited: 1
V. I. Kobylyansky
Fundamental and Clinical Medicine (2022) Vol. 7, Iss. 3, pp. 74-84
Open Access | Times Cited: 1
Efficacy of tocilizumab in treatment of COVID-19 pneumonia
Minal Shastri, Darshankumar Manubhai Raval, Ummayhany Bharmal, et al.
Lung India (2022) Vol. 39, Iss. 6, pp. 510-516
Open Access | Times Cited: 1
Minal Shastri, Darshankumar Manubhai Raval, Ummayhany Bharmal, et al.
Lung India (2022) Vol. 39, Iss. 6, pp. 510-516
Open Access | Times Cited: 1
“Efficacy of tocilizumab in treatment of COVID-19 pneumonia: A case–control study from a tertiary care hospital”
Sachinkumar Dole, M.S. Barthwal, CB Ashwin Ramesh, et al.
Lung India (2023) Vol. 40, Iss. 3, pp. 299-300
Open Access
Sachinkumar Dole, M.S. Barthwal, CB Ashwin Ramesh, et al.
Lung India (2023) Vol. 40, Iss. 3, pp. 299-300
Open Access
Some reflections on immunosuppressants and their delivery to the lungs by aerosol in the treatment of COVID-19
V. I. Kobylyansky
Medical Immunology (Russia) (2023) Vol. 25, Iss. 6, pp. 1307-1318
Open Access
V. I. Kobylyansky
Medical Immunology (Russia) (2023) Vol. 25, Iss. 6, pp. 1307-1318
Open Access
Evaluation of the inhaled immunosuppressants effectiveness in the treatment of COVID-19
V. I. Kobylyansky
Infectious diseases News Opinions Training (2023) Vol. 12, Iss. 4, pp. 81-89
Open Access
V. I. Kobylyansky
Infectious diseases News Opinions Training (2023) Vol. 12, Iss. 4, pp. 81-89
Open Access
